DHTAX
Price
$25.54
Change
-$0.27 (-1.05%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

DHTAX vs VMVAX

Header iconDHTAX vs VMVAX Comparison
Open Charts DHTAX vs VMVAXBanner chart's image
Diamond Hill Select I
Price$25.54
Change-$0.27 (-1.05%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DHTAX vs VMVAX Comparison Chart
Loading...
VS
DHTAX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHTAX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. DHTAX (589M). VMVAX pays higher dividends than DHTAX: VMVAX (2.14) vs DHTAX (0.19). DHTAX was incepted earlier than VMVAX: DHTAX (19 years) vs VMVAX (13 years). DHTAX is a more actively managed with annual turnover of: 60.00 vs. VMVAX (22.00). DHTAX has a lower initial minimum investment than VMVAX: DHTAX (2500) vs VMVAX (3000). DHTAX annual gain was more profitable for investors over the last year : 33.65 vs. VMVAX (25.35). DHTAX return over 5 years is better than : 70.57 vs. VMVAX (48.82).
DHTAXVMVAXDHTAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years13 years-
Gain YTD15.51314.946104%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets589M30.5B2%
Annual Yield % from dividends0.192.149%
Returns for 1 year33.6525.35133%
Returns for 3 years14.9320.7172%
Returns for 5 years70.5748.82145%
Returns for 10 years91.17100.8890%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio